Development of a practical synthesis of sumanirole

Pure and Applied Chemistry

Volumn 74, Issue 8, 2002, Pages 1359-1368

  Wuts, Peter G M ^a   Gu, Rui Lin ^a   Northuis, Jill M ^a   Kwan, Tricia A ^a   Beck, Doris M ^a   White, Michael J ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 QUINOLINOL; AZIRIDINE; DOPAMINE 2 RECEPTOR STIMULATING AGENT; PNU 95666E; SUMANIROLE; UNCLASSIFIED DRUG;

CHIRALITY; CONFERENCE PAPER; DRUG STRUCTURE; DRUG SYNTHESIS; PARKINSON DISEASE; PRIORITY JOURNAL; REACTION ANALYSIS;

EID: 0036695556     PISSN: 00334545     EISSN: None     Source Type: Journal    
DOI: 10.1351/pac200274081359     Document Type: Conference Paper

References (23)

1. P. Seeman and H. B. Niznik. FASEB J. 2737 (1990).
2. R. J. Coleman. Drugs Aging 2, 112 (1992).
3. R. F. Heier, L. A. Dolak, J. N. Duncan, D. K. Hyslop, M. F. Lipton, I. J. Martin, M. A. Mauragis, M. F. Piercey, N. F. Nichols, P. J. K. D. Schreur, M. W. Smith, M. W. Moon. J. Med. Chem. 40, 639 (1997).
4. For a review of some of the early approaches, see: P. G. M. Wuts. Curr Opin. Drug Discov. Devel. 2, 557 (1999).
5. A. G. Romero, W. H. Darlington, M. W. McMillan. J. Org. Chem. 63, 6582 (1997).
6. Bucherer reviews: M. S. Gibson. "Introduction of the Amino Group", in Chemistry of the Amino Group, pp. 37-77 (1968);
7. N. L. Drake. Org. React. 1, 105 (1942).
8. D. L. J. Comins and P. Sajan. Adv. Nitrogen Heterocycl. 2, 251 (1996).
9. 4 in 2.5 mL of DMF.
10. W. S. Saari, W. Halczenko, M. B. Freedman, B. H. Arison. J. Heterocycl. Chem. 19 (4), 837 (1982).
11. D. A. Evans, M. M. Faul, M. T. Bilodeau, B. A. Anderson, D. M. Barnes. J. Am. Chem. Soc. 115, 5328 (1993).
12. Z. Li, K. R. Conser, E. N. Jacobsen. J. Am. Chem. Soc. 115, 5326 (1993).
13. It should be noted that the original Evans work was restricted to trans olefins.
14. W. Zhang, J. L. Loebach, S. R. Wilson, E. N. Jacobsen. J. Am. Chem. Soc. 112, 2801 (1990).
15. R. F. Heier M. W. Moon W. T. Stolle J. A. Easter R. S. P. His. J. Labelled Compd. Radiopharm. 38, 1087 (1996).
16. Y. Tu, Z.-X. Wang, Y. Shi. J. Am. Chem. Soc. 118, 9806 (1996).
17. G. Li, H.-T. Chang, K. B. Sharpless. Angew. Chem. Int. Ed. Engl. 35 (4), 451 (1996).
18. C. E. Cerniglia. J. Ind. Microbiol. Biotechnol. 19, 324 (1997);
19. R. N. Patel, A. Banerjee, C. McNamee, D. Brzozowski, L. J. Szarka. "Method of chiral epoxidation of benzopyran or pyranopyridine derivatives using microorganisms", U.S. Patent 5,478,734 (1995);
20. T. A. Crabb, P. J. Dawson, R. O. Williams. J. Chem. Soc. Perkin Trans. I (11), 2535 (1980).
21. 4: 0.74 g/L; tap water to 1 L. Media E = pH 6.8, cerelose: 22 g/L; yeast extract: 10 g/L; malt peptone: 1 g/L; RO water to one litre.
22. A Daicel Chiralpak AD column, 100 x 2.5 mm, (Chiral Technologies Inc.) was used for chiral analysis. The mobile phase was heptane:isopropanol (75:25, v/v) isocratic 0-35 min, flow rate, 0.5 mL/min, ambient temperature, and detection, 224 nm.
23. M. L. Moore. Org. React. 7, 301 (1949).